VSTM FY 2021 Earnings — Verastem, Inc. Revenue & Financial Results | Market Cap Arena

VSTMVerastem, Inc.

$388M

FY 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M-97.7% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$61M-2991.2% margin

Net Income

-$71M-3468.1% margin

EPS (Diluted)

$-4.92

Cash Flow

Operating Cash Flow

-$54M

Free Cash Flow

-$54M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$109M

Total Liabilities

$21M

Stockholders' Equity

$88M

Cash & Equivalents

$21M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$89M	-97.7%
Gross Profit	$2M	$55M	-96.3%
Operating Income	-$61M	-$49M	-24.4%
Net Income	-$71M	-$68M	-5.1%